Abstract 12221: Reduction of Inappropriate Shocks Over Time in Hypertrophic Cardiomyopathy Patients With Subcutaneous Implantable Cardioverter-Defibrillators

Autor: Chockalingam Narayanan, William Gionfriddo, Srijan Shrestha, Benjamin Koethe, Benjamin Katcher, Ann Garlitski, Jonathan Weinstock, Munther Homoud, Barry Maron, Martin S Maron, Ethan J Rowin, Christopher Madias
Rok vydání: 2021
Předmět:
Zdroj: Circulation. 144
ISSN: 1524-4539
0009-7322
Popis: Introduction: Subcutaneous implantable cardioverter defibrillators (SICD) are an attractive option for sudden death (SCD) prevention in younger hypertrophic cardiomyopathy (HCM) patients. Conversely, SICDs have higher rate of inappropriate shock (IAS) when compared to transvenous devices. Objective: We characterize incidence of appropriate shock (AS) and IAS and analyze predictors of IAS in HCM SICD patients. Methods: Data was collected from HCM SICD patients from 2013 to 2021. We used multivariable logistic regression to assess for predictors of IAS in patients with > 6 mo follow up. Results: 94 HCM patients (age 47 ± 15 years) underwent SICD implant with mean follow up of 3.7 ± 2.0 year. Maximal LV thickness 20.5 ± 5.8 mm with massive hypertrophy (> 30 mm) in 10 patients (11.8%). Initial DFT with 65J was successful in 88 patients, with 5 more successful after device adjustment. 5 patients (5.9%) had 10 AS (3.2 AS per 100 pt-years). 10 patients (11.8%) had 19 IAS (6.0 IAS per 100 pt-years) due to T wave oversensing (n = 13), P wave oversensing (n = 2), atrial arrhythmia (n=2), and external noise (n = 1). IAS rate decreased over time, with IAS occurring in 8 patients of the initial half of the cohort and in only 2 of the second half. Time to IAS from implant was 11 ± 10.8 mo. QRS duration (OR 1.025, 95% CI 0.997-1.053; P = 0.084) showed trend to prediction of IAS, but no characteristic proved independently significant. Conclusions: This data adds to increasing evidence that in high-risk HCM patients, SICD represents a reliable treatment option for SCD prevention. IAS mainly due to cardiac oversensing, was seen in 11.8% of patients within this HCM cohort. IAS decreased over time, possibly due to improved patient selection, implant technique and device programming (SMART pass filter). A larger dataset is likely necessary to better understand this trend.
Databáze: OpenAIRE
Externí odkaz: